Evaluating Nanomedicines: Obstacles and Advancements
Detection of Bacterial Contamination in Nanoparticle Formulations by Agar Plate Test
Considerations and Some Practical Solutions to Overcome Nanoparticle Interference with LAL Assays and to Avoid Endotoxin Contamination in Nanoformulations
Elemental Analysis in Biological Matrices Using ICP-MS
PEG Quantitation Using Reversed Phase High Performance Liquid Chromatography and Charged Aerosol Detection
Quantitation of Surface Coating on Nanoparticles Using Thermogravimetric Analysis
Immunoelectron Microscopy for Visualization of Nanoparticles
Imaging of Liposomes by Transmission Electron Microscopy
Updated Method for In Vitro Analysis of Nanoparticle Hemolytic Properties
In Vitro Assessment of Nanoparticle Effects on Blood Coagulation
In Vitro Analysis of Nanoparticle Effects on the Zymosan Uptake by Phagocytic Cells
Assessing NLRP3 Inflammasome Activation by Nanoparticles
Analysis of Complement Activation by Nanoparticles
Methods for Analysis of Nanoparticle Immunosuppressive Properties In Vitro and In Vivo
Analysis of Pro-Inflammatory Cytokine and Type II Interferon Induction by Nanoparticles
Analysis of Nanoparticle Adjuvant Properties In Vivo
In Vitro and In Vivo Methods for Analysis of Nanoparticle Potential to Induce Delayed Type Hypersensitivity Reactions
Autophagy Monitoring Assay II: Imaging Autophagy Induction in LLC-PK1 Cells Using GFP-LC3 Protein Fusion Construct
Improved Ultrafiltration Method to Measure Drug Release from Nanomedicines Utilizing a Stable Isotope Tracer
Designing an In Vivo Efficacy Study of Nanomedicines for Preclinical Tumor Growth Inhibition.